References
- Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297.
- Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007;13(Suppl 6C):S5–S18.
- American Cancer Society. Colorectal cancer facts & figures 2011–2013. Atlanta (GA): American Cancer Society; 2011 [cited 2015 Nov 4]. Available from: http://www.cancer.org/research/cancerfactsfigures/colorectalcancerfactsfigures/colorectal-cancer-facts-figures-2011-2013-page
- American Cancer Society. Cancer facts & figures 2015. Atlanta (GA): American Cancer Society; 2015 [cited 2015 Nov 4]. Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/
- Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–658.
- Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use – United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881–888.
- Exact Sciences Corporation. CologuardTM patient guide. Madison (WI): Exact Sciences Corporation; 2013 [cited 2015 Nov 4]. Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf13/P130017c.pdf
- Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370(14):1298–1306.
- Samadder NJ, Curtin K, Tuohy TM, et al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology. 2014;146(4):950–960.
- US Food and Drug Administration. FDA approves first non-invasive DNA screening test for colorectal cancer. FDA News Release. Silver Spring (MD): US Food and Drug Administration; 2014 [cited 2015 Nov 4]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409021.htm
- Jones RM, Vernon SW, Woolf SH. Is discussion of colorectal cancer screening options associated with heightened patient confusion? Cancer Epidemiol Biomarkers Prev. 2010;19(11):2821–2825.
- Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696.
- Citarda F, Tomaselli G, Capocaccia R, et al. Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48(6):812–815.
- Winawer SJ, Zauber AG, Ho MN, et al. National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329(27):1977–1981.
- Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295(20):2366–2373.
- Siegel RL, Sahar L, Robbins A, et al. Where can colorectal cancer screening interventions have the most impact? Cancer Epidemiol Biomarkers Prev. 2015;24(8):1151–1156.